Lilly chief op-ed promises pharma breakthroughs; Strapped Spanish gov't mulls generics incentives;

 @FiercePharma: Lilly slices 200 sales and marketing jobs in biomedicine. Article | Follow @FiercePharma

> Can drugmakers like Eli Lilly continue to innovate amid the powerful headwinds of a challenging global healthcare environment? In an op-ed today, CEO John Lechleiter answers with a confident, "Yes!" Report

> The Spanish government has been told that its recent introduction of "overly harsh" pharmaceutical price-cutting measures needs to be balanced with initiatives to encourage the prescribing and dispensing of generic drugs. Report

> Watson Pharmaceuticals posted a higher-than-expected first-quarter profit, helped by sales of its generic heart drugs and international sales. Report

> Alcon is planning to rope in strategic manufacturing alliances and joint ventures with leading Indian drug manufacturers, the Business Standard reports. Report

> Astellas Pharma intends to emerge as a niche player in India, with a market-leading position in the transplantation-drug segment within five years and with forays into other areas such as urology and anti-infectives, a company official said. Report

> Vietnam's Ministry of Health ordered a halt to all selling of popular children's medicines following a recall by McNeil Consumer Healthcare in the U.S. Report

> One person was treated for possible smoke inhalation after a fire torched medical supplies at a Sandoz facility near Denver, CO. Report

Biotech News

 @FierceBiotech: Ignoring lawsuit, Bayer takes regorafenib into PhIII cancer study. Report | Follow @FierceBiotech 

 @JohnCFierce: A quick mental calculation gave me a $40M value on that CureVac round. But after the euro's fall, it's only $35M these days. | Follow @JohnCFierce

> Minnesota promotes 'sweet' tax credits. News

> Avexa shares tank on scrapped HIV program. Report

> Evotec inks drug discovery deal with Genentech. Article

> San Diego biotechs see increased revenue. Item

> CureVac nears crossroads for therapeutic cancer vax. Story

> Stem cell study shows early promise for MS. Item

Biotech IT News

> Hemispherx forms data-monitoring team. Story

> Blog: Recruit RA reps for social media team. News

> Mobile phone becomes tool for clinical trials. Report

> BioClinica to launch IVR/IWR as part of e-clinical offerings. Article

> CROs, trade groups tackle trial recruitment challenges. Report

> Tufts' Getz sees growing trial complexity. Item

 And Finally... A new analysis finds that the costs of treating cancer have nearly doubled over the past two decades. Report